Baseline characteristics of adults with eGFR ≥60 ml/min/1.73 m² by 25(OH)D groups.

<p>Baseline characteristics of adults with eGFR ≥60 ml/min/1.73 m² by 25(OH)D groups.</p

Total number of deaths by eGFR status 25[OH]D groups.

<p>Total number of deaths by eGFR status 25[OH]D groups.</p

Flowchart of individuals included in the analysis of the association between 25[OH]D and all-cause mortality.

<p>Flowchart of individuals included in the analysis of the association between 25[OH]D and all-cause mortality.</p

Age-, sex-, season- and race/ethnicity-adjusted mortality rates per 1,000 person-years by 25(OH)D groups among adults with eGFR <60 ml/min/1.73 m².

<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0047458#pone-0047458-g002" target="_blank">Figure 2</a> includes all participants (with eGFR <60 ml/min/1.73 m²) and under 3 exclusion strategies: 1) Exclusion of participants who died within one year of baseline examination; 2) Exclusion of participants who died within two years of baseline examination; 3) Exclusion of participants who died within three years of baseline examination. Rates were computed using Poisson regression analysis after grouping 25[OH] D values into 7 groups.</p

Baseline characteristics of study participants with eGFR<60 ml/min/1.73 m² by 25[OH]D groups.

*<p>Data are shown as mean (standard error) or percentages (standard error).</p

Age-, sex-, season- and race/ethnicity-adjusted mortality rates per 1,000 person-years by 25(OH)D groups among adults without eGFR <60 ml/min/1.73 m².

<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0047458#pone-0047458-g003" target="_blank">Figure 3</a> includes all participants (without eGFR <60 ml/min/1.73 m²) and under 3 exclusion strategies: 1) Exclusion of participants who died within one year of baseline examination; 2) Exclusion of participants who died within two years of baseline examination; 3) Exclusion of participants who died within three years of baseline examination. Rates were computed using Poisson regression analysis after grouping 25[OH] D values into 7 groups.</p

All-cause mortality rate per 1000 person-years (95% CI) and mortality rate ratios by 25[OH]D groups among participants with e GFR≥60 ml/min/1.73 m².

*<p>All-cause mortality rate per 1000 person-years.</p><p>Model adjusts for age, sex, race/ethnicity, season of 25[OH]D measurement, co-morbidities (cancer, MI, CHF, stroke, diabetes), BMI, SBP, eGFR, smoking, medication use and educational level.</p

Distribution of attributes, National Health and Nutrition Examination Survey 1999–2004, overall and by albuminuria status.

<p>P values use t-test for differences in means, and Wald chi-square test for proportions.</p>*<p>Note that values in the table are weighted to take into account the complex survey design; however, the counts of number of subjects with (n = 1326) and without albuminuria (n = 8032) are not weighted for the survey design.</p>†<p>Triglyceride levels available only for the subset (n = 4457) with fasting morning blood draw.</p

U.S. trends in total sugar availability, High Fructose Corn Syrup (HFCS) availability, soft drink consumption, and incident diabetic end-stage renal disease (ESRD) over time.

<p>Data on sweetener availability from USDA <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0003431#pone.0003431-USDA1" target="_blank">[38]</a>; soft drink consumption from Nielsen and Popkin <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0003431#pone.0003431-Nielsen1" target="_blank">[8]</a>; and incident diabetic ESRD from the United States Renal Data System <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0003431#pone.0003431-USRDS1" target="_blank">[54]</a>.</p

Proportion consuming 2+ sugary sodas (cells) by quartile of energy intake (rows) and body mass index (BMI) category (columns).

<p>Note: “Column differences” χ² p-value assess whether sugary soda consumption differs by level of caloric consumption within each BMI category. “Row differences” χ² p-value assess whether sugary soda consumption differs by BMI category within each level of energy intake.</p